Cargando…
Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade
BACKGROUND: Since the last major review of literature on the benefit of I-131 therapy, the continued debate on postoperative radioiodine treatment (RIT) in differentiated thyroid carcinoma (DTC) has led to a number of further studies being published on this topic. AIM: The aim of the present paper i...
Autores principales: | Verburg, Frederik A., Flux, Glenn, Giovanella, Luca, van Nostrand, Douglas, Muylle, Kristoff, Luster, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885024/ https://www.ncbi.nlm.nih.gov/pubmed/31616967 http://dx.doi.org/10.1007/s00259-019-04479-1 |
Ejemplares similares
-
Pediatric papillary thyroid cancer: current management challenges
por: Verburg, Frederik A, et al.
Publicado: (2016) -
New! F-18-based PET/CT for sodium-iodine-symporter-targeted imaging!
por: Verburg, Frederik A., et al.
Publicado: (2020) -
Efficacy of Dosimetric Versus Empiric Prescribed Activity of (131)I for Therapy of Differentiated Thyroid Cancer
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2011) -
Procalcitonin measurement to screen medullary thyroid carcinoma: A prospective evaluation in a series of 2705 patients with thyroid nodules
por: Giovanella, Luca, et al.
Publicado: (2018) -
Thyroid Hormone Withdrawal versus Recombinant Human TSH as Preparation for I-131 Therapy in Patients with Metastatic Thyroid Cancer: A Systematic Review and Meta-Analysis
por: Giovanella, Luca, et al.
Publicado: (2023)